Evidence map›Paper›PMID 25264766›Full record

ArticlePloS one2014

Non-instrumented incubation of a recombinase polymerase amplification assay for the rapid and sensitive detection of proviral HIV-1 DNA.

Lorraine Lillis, Dara Lehman, Mitra C Singhal, Jason Cantera, Jered Singleton, Paul Labarre, Anthony Toyama, Olaf Piepenburg, Mathew Parker, Robert Wood and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 157 citations in OpenAlex.

  1. Article
  2. Article
  3. Droplet Digital CRISPR for Nucleic Acid Detection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. A dual RPA-LFD assay for the simultaneous detection ofFrontiers in bioengineering and biotechnology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Malaria diagnostic update: From conventional to advanced method.Journal of clinical laboratory analysis · 2022
    Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Lorraine LillisPATH, Seattle, Washington, United States of America.
Dara LehmanFred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Mitra C SinghalPATH, Seattle, Washington, United States of America.
Jason CanteraPATH, Seattle, Washington, United States of America.
Jered SingletonPATH, Seattle, Washington, United States of America.
Paul LabarrePATH, Seattle, Washington, United States of America.
Anthony ToyamaPATH, Seattle, Washington, United States of America.
Olaf PiepenburgTwistDx Limited, Minerva Building, Babraham Research Campus, Babraham, Cambridge, United Kingdom.
Mathew ParkerTwistDx Limited, Minerva Building, Babraham Research Campus, Babraham, Cambridge, United Kingdom.
Robert WoodDepartment of Atmospheric Sciences, University of Washington, Seattle, Washington, United States of America.
Julie OverbaughFred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
David S BoylePATH, Seattle, Washington, United States of America.
Program for Appropriate Technology in Health · USFred Hutch Cancer Center · USTwistDx (United Kingdom) · GBUniversity of Washington · US

Funding

Recombinase Polymerase Amplification for Point-of-Care Diagnosis of Infant HIV-1R01AI097038 · NIAID · PATH · PI BOYLE, DAVID SCOTT · 2011 to 2013
$1.2M
NIAID NIH HHS R01 AI097038NIAID NIH HHS R01AI097038
6 · The paper itself

Abstract

Sensitive diagnostic tests for infectious diseases often employ nucleic acid amplification technologies (NAATs). However, most NAAT assays, including many isothermal amplification methods, require power-dependent instrumentation for incubation. For use in low resource settings (LRS), diagnostics that do not require consistent electricity supply would be ideal. Recombinase polymerase amplification (RPA) is an isothermal amplification technology that has been shown to typically work at temperatures ranging from 25-43°C, and does not require a stringent incubation temperature for optimal performance. Here we evaluate the ability to incubate an HIV-1 RPA assay, intended for use as an infant HIV diagnostic in LRS, at ambient temperatures or with a simple non-instrumented heat source. To determine the range of expected ambient temperatures in settings where an HIV-1 infant diagnostic would be of most use, a dataset of the seasonal range of daily temperatures in sub Saharan Africa was analyzed and revealed ambient temperatures as low as 10°C and rarely above 43°C. All 24 of 24 (100%) HIV-1 RPA reactions amplified when incubated for 20 minutes between 31°C and 43°C. The amplification from the HIV-1 RPA assay under investigation at temperatures was less consistent below 30°C. Thus, we developed a chemical heater to incubate HIV-1 RPA assays when ambient temperatures are between 10°C and 30°C. All 12/12 (100%) reactions amplified with chemical heat incubation from ambient temperatures of 15°C, 20°C, 25°C and 30°C. We also observed that incubation at 30 minutes improved assay performance at lower temperatures where detection was sporadic using 20 minutes incubation. We have demonstrated that incubation of the RPA HIV-1 assay via ambient temperatures or using chemical heaters yields similar results to using electrically powered devices. We propose that this RPA HIV-1 assay may not need dedicated equipment to be a highly sensitive tool to diagnose infant HIV-1 in LRS.

Indexed as

Africa South of the SaharaCell LineClimateDNA, ViralHIV-1HIV InfectionsHumansInfantMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesRecombinasesTemperatureDNA, ViralRecombinases

Identifiers

PMID25264766
PMCPMC4180440
OpenAlexW2040627454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.